Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA
TUESDAY, July 21, 2026-- For patients with rheumatoid arthritis (RA), the timing of Janus kinase (JAK) inhibitor initiation relative to administration of recombinant zoster vaccine (RZV) can affect early response and arthritis control, according...
Read more »